Reasons for withdrawal of patients from study, according to study group
| Reasons | Trimetazidine and diltiazem | Placebo and diltiazem | |||||
|---|---|---|---|---|---|---|---|
| No of patients | Mean No of days2-150 | No of patients | Mean No of days2-150 | ||||
| Lack of efficacy | 0 | – | 2 | 8.0 | |||
| Adverse reactions2-151 | 0 | – | 2 | 7.0 | |||
| Intercurrent illness2-152 | 1 | 27.0 | 2 | 27.0 | |||
| Refusal to continue | 2 | 5.5 | 2 | 6.0 | |||
| Total patients | 3 | – | 8 | – | |||
↵2-150 After start of study treatment.
↵2-151 In the placebo group, one patient withdrew because of palpitations, anxiety, and restlessness; and the other because of constipation.
↵2-152 Denotes one case of fever in the trimetazidine group; and two patients reporting sick in the placebo group who could not be followed up.